(Reuters) - George Scangos, the chief executive of Biogen Idec Inc (BIIB.O), is uncomfortable in the well-appointed office he inherited when he took the top job last July. Though his office is spacious -- it has its own adjacent conference room -- Scangos finds Biogen’s concrete and glass building, constructed on a former rock quarry, sterile.
